WASHINGTON, D.C. – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, and Congressman Earl L. “Buddy” Carter (GA-01), Chairman of the Subcommittee on Health, announced a hearing titled Examining the FDA’s Regulation of Over-the-Counter Monograph Drugs. 

“From providing relief to headaches, to alleviating symptoms of the common cold, over-the-counter drugs play an important part in helping Americans live healthier lives,” said Chairmen Guthrie and Carter. “This hearing will give Members an opportunity to hear from experts and stakeholders and how the FDA’s Over-The-Counter Monograph Drug User Fee Program is working and what challenges may persist.” 

Subcommittee on Health hearing titled Examining the FDA’s Regulation of Over-the-Counter Monograph Drugs 

WHAT: Subcommittee on Health hearing to discuss how the Food and Drug Administration regulates over-the-counter drugs. 

DATE: Tuesday, April 1, 2025 

TIME: 10:15 AM ET 

LOCATION: 2123 Rayburn House Office Building  

This notice is at the direction of the Chairmen. The hearing will be open to the public and press and will be live streamed online at energycommerce.house.gov. If you have any questions concerning the hearing, please contact Emma Schultheis with the Committee staff at Emma.Schultheis@mail.house.gov. If you have any press-related questions, please contact Matthew VanHyfte at Matthew.VanHyfte@mail.house.gov.

###